Overall rank by patents
#43,507
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Texas Biomedical Research Institute
USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
6
Total patents granted
7
CPC technology areas
12.7
Avg claims per patent
-50%
5-year filing velocity
The verdict
Texas holds 6 US patents across 7 technology areas, rank #43,507 of 50,000 tracked assignees.
- #43,507
- of 50,000 US assignees by volume
- Top 66%
- by Innovation Score (30.3/100)
- 12.7
- avg claims per patent
- -50%
- filing velocity, last 5 yrs
Portfolio overview
Texas Biomedical Research Institute has been granted 6 US utility patents between 2015 and 2024, placing Texas Biomedical Research Institute at rank #43,507 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.7 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Texas Biomedical Research Institute is one of the more focused assignees in the PatentsView dataset. By volume, Texas sits between Teufelberger Fiber ROPE Gmbh (6 patents, rank #43,503) and Thales Sa (6 patents, rank #43,511) - the closest US assignees by grant volume. The composite Innovation Score of 30.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 4 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Texas Biomedical Research Institute's 12.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Texas Biomedical Research Institute against peers pursuing similar technology classes.
Who files at Texas's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Teufelberger Fibe…
TEUFELBERGER FIBER ROPE GMBH
6 patents
- TEVA Medical
TEVA MEDICAL LTD.
6 patents
- TEWS Elektronik &…
TEWS Elektronik GmbH & Co. KG
6 patents
- TEXA Dynamics S R…
TEXA DYNAMICS S.R.L.
6 patents
- Tg-17
TG-17, Inc.
6 patents
- TH Products
TH Products, LLC
6 patents
- Thales DIS USA
THALES DIS USA Inc.
6 patents
- Thales
THALES SA
6 patents
- Texas Biomedical… ◀
TEXAS BIOMEDICAL RESEARCH INSTITUTE
6 patents
What this shows Texas holds 6 patents at rank #43,507, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Texas
By rank, the assignees closest to #43,507 in granted patent volume.
- Teufelberger Fiber ROPE Gmbh #43,503 · 6 patents
- TEVA Medical Ltd. #43,504 · 6 patents
- TEWS Elektronik Gmbh & Co. KG #43,505 · 6 patents
- TEXA Dynamics S.r.l. #43,506 · 6 patents
- TG-17, Inc. #43,508 · 6 patents
- TH Products, Llc #43,509 · 6 patents
- Thales DIS USA Inc. #43,510 · 6 patents
- Thales Sa #43,511 · 6 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Texas's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
Texas's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 66% higher than 34% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2018 | 2 | 33.3% |
| 2020 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Which technologies does Texas Biomedical Research Institute patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Texas Biomedical Research Institute hold?
Texas Biomedical Research Institute holds 6 US granted patents filed between 2015 and 2024, spanning 7 technology areas.
What is Texas Biomedical Research Institute's Innovation Score?
Texas Biomedical Research Institute has an Innovation Score of 30.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Texas Biomedical Research Institute focus on?
Texas Biomedical Research Institute's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 5 patents. The company has filed patents in 7 CPC subclasses total.
Is Texas Biomedical Research Institute's patent filing rate increasing or decreasing?
Texas Biomedical Research Institute's recent filing velocity is -50% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Texas Biomedical Research Institute's patents?
Texas Biomedical Research Institute's patents average 12.7 claims each. This falls within the standard range, providing solid legal coverage.
How is the Texas Biomedical Research Institute patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Texas's 6 grants land it in the top 66% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Texas ranks #43,507 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.